Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,701.00
Ask: 1,701.50
Change: 32.00 (1.91%)
Spread: 0.50 (0.029%)
Open: 1,685.50
High: 1,718.50
Low: 1,673.00
Prev. Close: 1,673.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Asian data lifts stocks early on

Mon, 02nd Jul 2012 08:30

- Chinese, Japanese data comes in better than expected- RBS falls on Libor issues- Barclays Chairman resignsLondon's blue chips edged higher on Monday morning after manufacturing data in China and Japan boosted sentiment.China's purchasing managers' index (PMI) fell from 50.4 to 50.2 last month, according to the National Bureau of Statistics and China Federation of Logistics and Purchasing, beating forecasts of around 49.9.Meanwhile, Japan's Tankan manufacturers' sentiment survey improved from minus four to minus one in the second quarter, compared to expectations of an unchanged ready.Investors will be looking ahead to policy decisions in both the UK and Europe around Thursday lunchtime. The Monetary Policy Committee (MPC) will be revealing its policy decision with the majority of economists expecting the Bank of England (BoE) to ramp up its asset purchase programme while keeping rates where they are.The European Central Bank (ECB) is anticipated to slash its main refinancing rate to a record-low 0.75%, compared with the current 1% level. 48 of the 71 economists surveyed by Reuters expect a reduction. FTSE 100: Banks continue to be dampened by Libor scandalRoyal Bank of Scotland (RBS) was a heavy faller after Oriel Securities downgraded its rating on the stock to 'hold'. It was revealed at the weekend that the bank had sacked four of its traders last year over the alleged manipulation of interbank lending rates (London Interbank Offered Rate, or LIBOR). Some market reports said that some 10 traders were dismissed, citing unidentified sources.The news comes after last week's revelation that banking peer Barclays had been fined £290m after it was found attempting to control submissions for LIBOR to benefit its interest rate derivatives. The issue prompted the lender's Chairman Marcus Agius to resign this morning. He said he is "truly sorry" that the bank's customers, clients, employees and shareholders have been let down. Barclay swung between gains and losses early on following last week's sell-off.Insurance group Aviva rose after announcing that Chairman Lord Sharman retired as Chairman on June 30th. John McFarlane has taken over.Pharmaceuticals giant AstraZeneca edged higher after saying that Bristol-Myers Squibb's acquisition of Amylin Pharmaceuticals will strengthen the leadership position of its diabetes alliance with Bristol-Myers in a "growing area of high unmet medical need". Astra will make a payment of $3.4bn in cash to Amylin once it becomes a wholly-owned subsidiary of Bristol-Myers.Sector peer GlaxoSmithKline also advanced after revealing positive results from four pivotal phase III studies for its once-daily COPD treatment. The company said that the results of the studies support its intention to commence global regulatory submissions for the treatment from the end of 2012.Serco, the international services company, rose after it signed an agreement to dispose of most of its operations in Germany in a transaction with the local management team.Media giant WPP was in demand after announcing another acquisition; it has agreed to acquire the South Korean media planning and buying agency, Alchemedia, which will be merged into its GroupM Korea subsidiary.FTSE 250: Catlin falls after broker downgradeInsurance group Catlin fell after Jefferies downgraded the stock to 'hold' as part of its review into the European insurance industry: "With Catlin now close to our price target, we downgrade to 'hold' also noting higher end US windstorm exposure and a broadly untouched reinsurance deductible."Oil and gas group SOCO International jumped after entering into a 'conditional' agreement with Lizeroux Oil & Gas to acquire the 20% minority interest in SOCO Vietnam that the group does not already own. FTSE 100 - RisersStandard Chartered (STAN) 1,418.50p +2.46%Barclays (BARC) 166.00p +1.93%WPP (WPP) 786.00p +1.68%Aviva (AV.) 276.80p +1.54%Burberry Group (BRBY) 1,345.00p +1.51%Prudential (PRU) 748.50p +1.42%Lloyds Banking Group (LLOY) 31.50p +1.27%BP (BP.) 427.20p +1.24%G4S (GFS) 282.40p +1.18%Tullow Oil (TLW) 1,487.00p +1.16%FTSE 100 - FallersXstrata (XTA) 780.20p -2.30%Shire Plc (SHP) 1,796.00p -1.97%Glencore International (GLEN) 290.45p -1.73%Royal Bank of Scotland Group (RBS) 211.70p -1.67%Tesco (TSCO) 306.45p -1.16%Vodafone Group (VOD) 177.45p -1.00%Evraz (EVR) 258.30p -0.92%British Sky Broadcasting Group (BSY) 690.50p -0.86%Smith & Nephew (SN.) 632.50p -0.78%International Consolidated Airlines Group SA (CDI) (IAG) 158.30p -0.75%FTSE 250 - RisersSoco International (SIA) 302.80p +4.63%Imagination Technologies Group (IMG) 487.60p +4.50%Aquarius Platinum Ltd. (AQP) 47.40p +3.81%Essar Energy (ESSR) 125.90p +3.20%Invensys (ISYS) 229.00p +2.83%BH Global Ltd. USD Shares (BHGU) 11.45 +2.69%Fenner (FENR) 370.70p +2.60%Shanks Group (SKS) 78.30p +2.55%FirstGroup (FGP) 229.40p +2.27%TR Property Inv Trust (TRY) 151.30p +2.23%FTSE 250 - FallersSpirit Pub Company (SPRT) 49.50p -2.46%Catlin Group Ltd. (CGL) 417.80p -1.81%Victrex (VCT) 1,249.00p -1.73%Cranswick (CWK) 801.00p -1.72%Halfords Group (HFD) 225.50p -1.61%New World Resources A Shares (NWR) 318.60p -1.51%Barr (A.G.) (BAG) 393.60p -1.40%Ruspetro (RPO) 133.40p -1.26%easyJet (EZJ) 525.50p -1.13%Renishaw (RSW) 1,386.00p -1.00%BC
More News
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.